Skinvisible, Inc. SKVI

SKVI Company Overview

Skinvisible, Inc. (OTC: SKVI) is a U.S.-based pharmaceutical and dermatology-focused company that develops topical and transdermal drug delivery technologies. The company operates primarily in the healthcare and specialty pharmaceutical industries, with a focus on over-the-counter (OTC), prescription dermatological, and cosmetic applications. Its core business model centers on licensing and commercializing proprietary topical formulations and delivery systems designed to improve skin penetration, stability, and patient usability.

The company is best known for its proprietary Invisicare® technology platform, a polymer-based topical delivery system intended to enhance absorption and reduce residue on the skin. Skinvisible has historically pursued partnerships and licensing agreements with manufacturers and distributors rather than operating as a large-scale pharmaceutical manufacturer itself. The company evolved from a technology development enterprise into a commercialization-focused business targeting niche dermatology and personal care markets. Public filings and company disclosures indicate that Skinvisible has concentrated much of its effort on intellectual property development, licensing opportunities, and international commercialization relationships.